Cargando…

Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy

In this study redox-sensitive (RS) liposomes manufactured using 10,10′-diselanediylbis decanoic acid (DDA), an organoselenium RS compound, to enhance the therapeutic performance of doxorubicin (Dox). The DDA structure was confirmed by 1H NMR and LC–MS/MS. Various liposomal formulations (33 formulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirhadi, Elaheh, Mashreghi, Mohammad, Askarizadeh, Anis, Mehrabian, Amin, Alavizadeh, Seyedeh Hoda, Arabi, Leila, Badiee, Ali, Jaafari, Mahmoud Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253031/ https://www.ncbi.nlm.nih.gov/pubmed/35788647 http://dx.doi.org/10.1038/s41598-022-15239-x

Ejemplares similares

Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy
por: Askarizadeh, Anis, et al.
Publicado: (2023)

The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity
por: Dadpour, Saba, et al.
Publicado: (2022)

The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice
por: Mehrabian, Amin, et al.
Publicado: (2023)

Preparation, characterization, and biodistribution of glutathione PEGylated nanoliposomal doxorubicin for brain drug delivery with a post-insertion approach
por: Mehrabian, Amin, et al.
Publicado: (2022)

Nanocarriers Call the Last Shot in the Treatment of Brain Cancers
por: Mehrabian, Amin, et al.
Publicado: (2022)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids
por: Hatamipour, Mahdi, et al.
Publicado: (2019)

Sphingomyelin liposome bearing whole Leishmania lysate antigens induce strong Th2 immune response in BALB/c mice
por: Biari, Nazanin, et al.
Publicado: (2021)

Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
por: Mashreghi, Mohammad, et al.
Publicado: (2020)

Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
por: Nik, Maryam Ebrahimi, et al.
Publicado: (2019)

Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
por: Nik, Maryam Ebrahimi, et al.
Publicado: (2020)

Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2023)

Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects
por: Shariat, Sheida, et al.
Publicado: (2015)

Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model
por: Golali, Ensieh, et al.
Publicado: (2012)

CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice
por: Soleimani, Anvar, et al.
Publicado: (2022)

Pharmacokinetics of a liposomal formulation of doxorubicin in rats
por: Liu, Zongyu, et al.
Publicado: (2017)

Evaluation of Immune Response against Leishmaniasis in BALB/c Mice Immunized with Cationic DOTAP/DOPE/CHOL Liposomes Containing Soluble Leishmania major Antigens
por: HOJATIZADE, Mansure, et al.
Publicado: (2019)

Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy
por: Yazdani, Mona, et al.
Publicado: (2021)

Optimization of a Method to Prepare Liposomes Containing HER2/Neu- Derived Peptide as a Vaccine Delivery System for Breast Cancer
por: Shariat, Sheyda, et al.
Publicado: (2014)

Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy
por: Yazdani, Mona, et al.
Publicado: (2020)

Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer
por: Nourbakhsh, Mahnaz, et al.
Publicado: (2015)

Sphingomyelin Liposomes Containing Soluble Leishmania major antigens Induced Strong Th2 Immune Response in BALB/c Mice
por: Chavoshian, Omid, et al.
Publicado: (2013)

Development of RNA aptamers as molecular probes for HER2(+) breast cancer study using cell-SELEX
por: Moosavian, Seyedeh Alia, et al.
Publicado: (2015)

Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells
por: Amin, Mohamadreza, et al.
Publicado: (2018)

Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides
por: Amin, Mohamadreza, et al.
Publicado: (2022)

Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2018)

Ehrlich tumor inhibition using doxorubicin containing liposomes
por: Elbialy, Nihal Saad, et al.
Publicado: (2015)

The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice
por: Hejazi, H, et al.
Publicado: (2010)

Liposomal and Non-Liposomal Formulations of Vitamin C: Comparison of the Antihypertensive and Vascular Modifying Activity in Renovascular Hypertensive Rats
por: Khalili, Azadeh, et al.
Publicado: (2020)

Application of ensemble machine learning approach to assess the factors affecting size and polydispersity index of liposomal nanoparticles
por: Hoseini, Benyamin, et al.
Publicado: (2023)

Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation
por: Nordström, Rickard, et al.
Publicado: (2021)

Anti-inflammatory efficacy of Berberine Nanomicelle for improvement of cerebral ischemia: formulation, characterization and evaluation in bilateral common carotid artery occlusion rat model
por: Azadi, Roza, et al.
Publicado: (2021)

Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006)

Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
por: Fukuda, Akiho, et al.
Publicado: (2017)

A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines
por: Haghiralsadat, Fateme, et al.
Publicado: (2017)

Primary bilateral ovarian involvement in Burkitt's lymphoma with an adnexal Torsion‐like manifestation: A case report
por: Pourghasemian, Mehdi, et al.
Publicado: (2021)

Anti-tumor activity of silymarin nanoliposomes in combination with iron: In vitro and in vivo study
por: Doagooyan, Maham, et al.
Publicado: (2023)

Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy
por: Vakili-Ghartavol, Roghayyeh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ij1tq67lf5um64cqhpjbrv66d5